COVID-19
Pharmafile.com’s weekly COVID-19 news round-up
June 3, 2020Research and Development COVID-19, coronavirus
COVID-19 treatments dominate the news this week as Russia is set to start its roll out of the anti-viral drug …
Eli Lilly launches clinical trial of COVID-19 antibody treatment
June 2, 2020Manufacturing and Production COVID-19, coronavirus
Eli Lilly has announced they have started an early stage human trial to test an antibody treatment against coronavirus. The …
Antidepressant Zoloft falls into shortage due to anxiety around COVID-19
June 2, 2020Manufacturing and Production COVID-19, coronavirus
The FDA has listed the antidepressant Zoloft to its catalogue of drugs that are in short supply in the United …
Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows
June 2, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …
How Big Brother is helping to fight COVID-19
June 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace
Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
Russia to begin administering anti-viral COVID-19 drug next week
June 1, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Russia, coronavirus, pandemic, virus
Russia will start its roll out of the anti-viral drug Avifavir (favipiravir) to COVID-19 patients next week, according to the …
US donates $1 billion to Oxford University’s COVID-19 vaccine in exchange for 300 million doses
June 1, 2020Sales and Marketing COVID-19, coronavirus
The US has given $1 billion to AstraZeneca to advance the development and production of the vaccine they are creating …
First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment
May 29, 2020Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir
The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
Top Ten most popular articles on Pharmafile.com this week
May 29, 2020Medical Communications COVID-19, coronavirus, top 10
GlaxoSmithKline features prominently in the news this week, as they pledged to pay a cash bonus of £1,500 to staff …
GlaxoSmithKline commits to the production of one billion doses of COVID-19 vaccine adjuvant in 2021
May 28, 2020Manufacturing and Production COVID-19, GSK, coronavirus, pharma, vaccines
GlaxoSmithKline has just come forward to commit to the manufacture and distribution of one billion doses of vaccine adjuvant against …
European countries reject hydroxychloroquine treatments for COVID-19
May 28, 2020Business Services COVID-19, coronavirus, hydroxychloroquine
Multiple European countries have rejected the use of hydroxychloroquine in patients suffering from coronavirus, due to a lack of evidence …
The June 2020 issue of Pharmafocus is available to read free online now!
May 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access
The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …
Pharmafile.com’s weekly COVID-19 news round-up
May 27, 2020Research and Development COVID-19, coronavirus, coronavirus round up
COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …
Scientists working on UK COVID-19 vaccine say there is now only a 50% chance of success due to falling cases
May 26, 2020Manufacturing and Production COVID-19, coronavirus
Researchers working on a COVID-19 vaccine are facing a race against time due to falling rates of the virus threatening …
Hot and humid weather can slow COVID-19 transmission, new study finds
May 26, 2020Manufacturing and Production COVID-19, coronavirus
A new study from the Massachusetts Institute of Technology, Harvard, Virginia Tech and the University of Connecticut has shown that …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
